Cargando…
Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening
The potential use of clinically approved beta-lactams for Buruli ulcer (BU) treatment was investigated with representative classes analyzed in vitro for activity against Mycobacterium ulcerans. Beta-lactams tested were effective alone and displayed a strong synergistic profile in combination with an...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366712/ https://www.ncbi.nlm.nih.gov/pubmed/30689630 http://dx.doi.org/10.1371/journal.pntd.0007126 |